BioSpace News Archive

Banner|Aetna, the Arizona health plan owned by Banner Health and Aetna, today announced a collaboration with 98point6, an on-demand, text-based primary care service that delivers personalized consultation, diagnosis and treatment to patients across the country

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI), the pioneer of orthopedic medical imaging 2D/3D, today announces consolidated results for the full year ended December 31, 2018, and its first quarter 2019 consolidated revenues as adopted by the Board of Directors on April 16, 2019.

On behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, the Honourable Patricia A. Hajdu, Minister of Employment, Workforce Development and Labour, will announce federal support to help prevent youth dating violence.

Positive results from the STEMTRA Phase 2 trial were presented today at the American Association of Neurological Surgeons (AANS) annual scientific meeting

On Wednesday, April 17, Northrop Grumman’s Cygnus resupply ship will launch on a cargo resupply mission heading to the International Space Station.

Western Governors University and Service Employees International Union-United Healthcare Workers West announced a new partnership aimed at closing the talent gap facing California’s, even the nation’s, healthcare workforce and putting thousands of students on the road to sustainable careers.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that new data demonstrating the capabilities of the AIM™ capsid library in cystic fibrosis and retinal disorders will be presented at the American Society of Gene and Cell Therapy 22nd Annual Meeting,

Mercom Capital Group, llc, a global communications and research firm, released its report on funding and merger and acquisition (M&A) activity for the Digital Health (Healthcare Information Technology) sector for the first quarter of 2019.

Universal Health Services, Inc. announced that it will report results for its first quarter ended March 31, 2019 after the market closes on Thursday, April 25, 2019.

INVO Bioscience, Inc. announced its fourth quarter and year end financial results for the periods ended December 31, 2018 as well as recent highlights.